All Stories

  1. Outcome and Oxygenation Response to Airway Pressure Release Ventilation (APRV) Used as a Rescue Strategy for Severe Hypoxemic Respiratory Failure—An Observational Study
  2. Effects of Sample Deposition Medium and Drying on Spectroscopic Quantification of Lipid Biomarkers in Respiratory Distress Syndrome
  3. Fabrication of cellophane-based microfluidic devices using laser direct-write approach
  4. Identification and antimicrobial susceptibility testing of MRSA using miniaturized fluidic wells laser-patterned on transparent substrate
  5. Low-cost colourimetric biosensing using laser-patterned cellophane-based fluidic devices
  6. Expression of cell-surface activation markers on human CD15+ cells after selected non esterified fatty acid supplementations
  7. The role of corticosteroids in the management of non-COVID-19 severe community-acquired pneumonia in the intensive care unit: A narrative review
  8. Hyperoxia and Surfactant Dysfunction in Critical Illness: Insights and Future Therapeutic Prospects
  9. Severe viral infections requiring intensive care unit admissions- aetiology, co-infections, respiratory interventions and outcomes
  10. Conservative Oxygen Therapy in Mechanically Ventilated Critically Ill Adult Patients
  11. Dexmedetomidine- or Clonidine-Based Sedation Compared With Propofol in Critically Ill Patients
  12. Cost-Effectiveness of α2 Agonists for Intravenous Sedation in Patients With Critical Illness
  13. Improving physical function with physiotherapy assistants following intensive care unit admission (EMPRESS): A randomised controlled feasibility study
  14. Evaluation of the physiological variables and scoring systems at intensive care discharge as predictors of clinical deterioration and readmission: a single-centre retrospective study
  15. Corticosteroids for the management of severe community-acquired pneumonia: A UK-wide survey
  16. The tear production of tecovirimat in a single hospitalized mpox patient: a pharmacokinetic analysis
  17. Lung Ultrasound in Critical Care: A Narrative Review
  18. Physiology and pathophysiology of mucus and mucolytic use in critically ill patients
  19. Pre-Hospital Critical Care for Out-of-Hospital Cardiac Arrests with Return of Spontaneous Circulation: A Retrospective Observational Study
  20. Immunoglobulin unresponsive Guillain-Barré syndrome: rinse or repeat? A systematic review
  21. Predictors of mortality for blunt trauma patients in intensive care: A retrospective cohort study
  22. Exploring Antibacterial Usage and Pathogen Surveillance over Five Years in a Tertiary Referral Teaching Hospital Adult General Intensive Care Unit (ICU)
  23. Management of adult mechanically ventilated patients: A UK-wide survey
  24. Best Abstracts
  25. Predictors of mortality for blunt trauma patients in intensive care: A retrospective cohort study
  26. Surfactant Phospholipid Kinetics in Ventilated Children after Therapeutic Surfactant Supplementation
  27. Characteristics, Management, and Outcomes of Acute Life-Threatening Asthma in Adult Intensive Care
  28. Intensive Care Management of Severe Hyponatraemia—An Observational Study
  29. Predictors of mortality for blunt trauma patients in intensive care: A retrospective cohort study
  30. Towards quantifying biomarkers for respiratory distress in preterm infants: Machine learning on mid infrared spectroscopy of lipid mixtures
  31. Oxidative stress, redox status and surfactant metabolism in mechanically ventilated patients receiving different approaches to oxygen therapy (MecROX): An observational study protocol for mechanistic evaluation
  32. Predictors of mortality for blunt trauma patients in intensive care: A retrospective cohort study
  33. Particles in Exhaled Air (PExA): Clinical Uses and Future Implications
  34. Oxidative stress, redox status and surfactant metabolism in mechanically ventilated patients receiving different approaches to oxygen therapy (MecROX): An observational study protocol for mechanistic evaluation
  35. Particles in Exhaled Air (PExA): Clinical Uses and Future Implications
  36. Author Correction: Para-infectious brain injury in COVID-19 persists at follow-up despite attenuated cytokine and autoantibody responses
  37. Large-scale phenotyping of patients with long COVID post-hospitalization reveals mechanistic subtypes of disease
  38. In Vivo Cellular Phosphatidylcholine Kinetics of CD15+ Leucocytes and CD3+ T-Lymphocytes in Adults with Acute Respiratory Distress Syndrome
  39. Management of Acute Life-Threatening Asthma Exacerbations in the Intensive Care Unit
  40. Characterization of Binary Liposome with Raman Spectroscopy for Targeted Nanomedicine
  41. Non-Invasive Ventilation for Community-Acquired Pneumonia: Outcomes and Predictors of Failure from an ICU Cohort
  42. Organisation and delivery of a dedicated multidisciplinary prone ventilation team in the intensive care unit: Strategies and lessons from COVID-19
  43. Delayed Mucosal Antiviral Responses Despite Robust Peripheral Inflammation in Fatal COVID-19
  44. Para-infectious brain injury in COVID-19 persists at follow-up despite attenuated cytokine and autoantibody responses
  45. Simvastatin in Critically Ill Patients with Covid-19
  46. A randomized controlled trial of nebulized surfactant for the treatment of severe COVID-19 in adults (COVSurf trial)
  47. Severe Parainfluenza Viral Infection—A Retrospective Study of Adult Intensive Care Patients
  48. Intravenous Vitamin C for Patients Hospitalized With COVID-19
  49. Alveolar Hyperoxia and Exacerbation of Lung Injury in Critically Ill SARS-CoV-2 Pneumonia
  50. International Pediatric COVID-19 Severity Over the Course of the Pandemic
  51. Pulmonary Surfactant in Adult ARDS: Current Perspectives and Future Directions
  52. Predictors of mortality for major trauma patients in intensive care: A retrospective cohort study
  53. Repair of Acute Respiratory Distress Syndrome in COVID-19 by Stromal Cells (REALIST-COVID Trial): A Multicenter, Randomized, Controlled Clinical Trial
  54. Prone Positioning in Mechanically Ventilated COVID-19 Patients: Timing of Initiation and Outcomes
  55. Provision of Microbiology, Infection Services and Antimicrobial Stewardship in Intensive Care: A Survey across the Critical Care Networks in England and Wales
  56. Effect of Angiotensin-Converting Enzyme Inhibitor and Angiotensin Receptor Blocker Initiation on Organ Support–Free Days in Patients Hospitalized With COVID-19
  57. The P323L substitution in the SARS-CoV-2 polymerase (NSP12) confers a selective advantage during infection
  58. Long-term (180-Day) Outcomes in Critically Ill Patients With COVID-19 in the REMAP-CAP Randomized Clinical Trial
  59. Detailed Analysis of Primary Non-invasive Respiratory Support and Outcomes of Subjects With COVID-19 Acute Hypoxaemic Respiratory Failure
  60. The association between iron deficiency and outcomes: a secondary analysis of the intravenous iron therapy to treat iron deficiency anaemia in patients undergoing major abdominal surgery (PREVENTT) trial
  61. Molecular point-of-care testing for lower respiratory tract pathogens improves safe antibiotic de-escalation in patients with pneumonia in the ICU: Results of a randomised controlled trial
  62. SARS-CoV-2-specific nasal IgA wanes 9 months after hospitalisation with COVID-19 and is not induced by subsequent vaccination
  63. Alternative pathway dysregulation in tissues drives sustained complement activation and predicts outcome across the disease course in COVID‐19
  64. S44 Repair of acute respiratory distress syndrome in COVID-19 by stromal cells (REALIST-COVID trial): 1 year follow up for safety and pulmonary dysfunction
  65. Viral Coinfections in Hospitalized Coronavirus Disease 2019 Patients Recruited to the International Severe Acute Respiratory and Emerging Infections Consortium WHO Clinical Characterisation Protocol UK Study
  66. Body mass index and clinical outcome of severe COVID-19 patients with acute hypoxic respiratory failure: Unravelling the “obesity paradox” phenomenon
  67. Aspergillus in COVID-19 intensive care unit; what is lurking above your head?
  68. Caring for COVID‐19 patients through a pandemic in the intensive care setting: A narrative review
  69. Antimicrobial stewardship programmes focused on de-escalation: a narrative review of efficacy and risks
  70. Dynamic blood oxygen indices in mechanically ventilated COVID-19 patients with acute hypoxic respiratory failure: A cohort study
  71. Procalcitonin Is Not a Reliable Biomarker of Bacterial Coinfection in People With Coronavirus Disease 2019 Undergoing Microbiological Investigation at the Time of Hospital Admission
  72. Plasma and Airway Levels of Surfactant Protein D Degradation Reflect Progression of ARDS in Ventilated Patients with SARS-CoV-2
  73. Repair of Acute Respiratory Distress Syndrome in COVID-19 by Stromal Cell Administration (REALIST-COVID) Phase 2 Randomised Controlled Trial
  74. Distinct clinical symptom patterns in patients hospitalised with COVID-19 in an analysis of 59,011 patients in the ISARIC-4C study
  75. Effect of Antiplatelet Therapy on Survival and Organ Support–Free Days in Critically Ill Patients With COVID-19
  76. Compassionate use of Pulmonary Vasodilators in Acute Severe Hypoxic Respiratory Failure due to COVID-19
  77. Implementation of corticosteroids in treatment of COVID-19 in the ISARIC WHO Clinical Characterisation Protocol UK: prospective, cohort study
  78. Improving physical function of patients following intensive care unit admission (EMPRESS): protocol of a randomised controlled feasibility trial
  79. Severe COVID‐19 pneumonia in an intensive care setting and comparisons with historic severe viral pneumonia due to other viruses
  80. Rapid Phospholipid Turnover after Surfactant Nebulization in Severe COVID-19 Infection: A Randomized Clinical Trial
  81. SARS-CoV-2 Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses
  82. Biomarker identification using dynamic time warping analysis: a longitudinal cohort study of patients with COVID-19 in a UK tertiary hospital
  83. Wave comparisons of clinical characteristics and outcomes of COVID-19 admissions - Exploring the impact of treatment and strain dynamics
  84. Impact of cardiometabolic multimorbidity and ethnicity on cardiovascular/renal complications in patients with COVID-19
  85. Prospective validation of the 4C prognostic models for adults hospitalised with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol
  86. Effect of Convalescent Plasma on Organ Support–Free Days in Critically Ill Patients With COVID-19
  87. The impact of viral mutations on recognition by SARS-CoV-2 specific T cells
  88. A prenylated dsRNA sensor protects against severe COVID-19
  89. Acute kidney injury in patients hospitalized with COVID-19 from the ISARIC WHO CCP-UK Study: a prospective, multicentre cohort study
  90. Vitamin D insufficiency in COVID-19 and influenza A, and critical illness survivors: a cross-sectional study
  91. Can a quantitative assessment of SARS-CoV-2 PCR predict degree of severity and outcomes in critical care patients with COVID-19?
  92. Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19
  93. Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19
  94. Co-infections, secondary infections, and antimicrobial use in patients hospitalised with COVID-19 during the first pandemic wave from the ISARIC WHO CCP-UK study: a multicentre, prospective cohort study
  95. Predictive Role of Haematological Determinants on Outcomes of Critically Ill COVID-19 Patients Admitted to Intensive Care Unit
  96. Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial
  97. Mapping the human genetic architecture of COVID-19
  98. Characterisation of in-hospital complications associated with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol UK: a prospective, multicentre cohort study
  99. Changes in in-hospital mortality in the first wave of COVID-19: a multicentre prospective observational cohort study using the WHO Clinical Characterisation Protocol UK
  100. Non-steroidal anti-inflammatory drug use and outcomes of COVID-19 in the ISARIC Clinical Characterisation Protocol UK cohort: a matched, prospective cohort study
  101. Severe COVID-19 pneumonia in an intensive care setting and comparisons with historic severe viral pneumonia due to other viruses
  102. Importance of patient bed pathways and length of stay differences in predicting COVID-19 hospital bed occupancy in England
  103. Methodology to detect oxidised phospholipids and their relevance in disease
  104. Recombinant ADAMTS13 reduces abnormally up-regulated von Willebrand factor in plasma from patients with severe COVID-19
  105. Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19
  106. Development and validation of the ISARIC 4C Deterioration model for adults hospitalised with COVID-19: a prospective cohort study
  107. Intensive care physicians’ perceptions of the diagnosis & management of patients with acute hypoxic respiratory failure associated with COVID-19: A UK based survey
  108. Clinical characteristics and outcome of critically ill COVID-19 patients with acute kidney injury: a single centre cohort study
  109. Inflammatory profiles across the spectrum of disease reveal a distinct role for GM-CSF in severe COVID-19
  110. Risk of adverse outcomes in patients with underlying respiratory conditions admitted to hospital with COVID-19: a national, multicentre prospective cohort study using the ISARIC WHO Clinical Characterisation Protocol UK
  111. Vitamin D levels and intensive care unit outcomes of a cohort of critically ill COVID-19 patients
  112. Research Evaluation Alongside Clinical Treatment in COVID-19 (REACT COVID-19): an observational and biobanking study
  113. Outcome of Hospitalization for COVID-19 in Patients with Interstitial Lung Disease. An International Multicenter Study
  114. Nebulised surfactant for the treatment of severe COVID-19 in adults (COV-Surf): A structured summary of a study protocol for a randomized controlled trial
  115. Detection of neutralising antibodies to SARS-CoV-2 to determine population exposure in Scottish blood donors between March and May 2020
  116. Goal-directed haemodynamic therapy (GDHT) in surgical patients: systematic review and meta-analysis of the impact of GDHT on post-operative pulmonary complications
  117. Effect of Hydrocortisone on Mortality and Organ Support in Patients With Severe COVID-19
  118. In-hospital cardiac arrest audit: An audit reviewing outcomes
  119. Noninvasive ventilation for COVID-19-associated acute hypoxaemic respiratory failure: experience from a single centre
  120. Prediction of mortality in critically-ill elderly trauma patients: a single centre retrospective observational study and comparison of the performance of trauma scores
  121. Inflammatory phenotyping predicts clinical outcome in COVID-19
  122. Recurrent Pneumothorax in a Critically Ill Ventilated COVID-19 Patient
  123. Risk stratification of patients admitted to hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: development and validation of the 4C Mortality Score
  124. Procalcitonin as an antibiotic stewardship tool in COVID-19 patients in the intensive care unit
  125. Clinical characteristics of children and young people admitted to hospital with covid-19 in United Kingdom: prospective multicentre observational cohort study
  126. Conscious prone positioning during non-invasive ventilation in COVID-19 patients: experience from a single centre
  127. Successful treatment of chronic myelomonocytic leukaemia with hydroxycarbamide in a patient presenting with acute hypoxic respiratory failure due to COVID‐19 pneumonia
  128. Clinical characteristics of children and young people hospitalised with covid-19 in the United Kingdom: prospective multicentre observational cohort study
  129. Clinical characteristics and outcome of critically ill COVID-19 patients with Acute Kidney Injury: A single centre cohort study
  130. Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study
  131. P196 Outcome of COPD patients started on inpatient domiciliary NIV following an acute admission with hypercapnic respiratory failure
  132. Immunonutrition for Adults With ARDS: Results From a Cochrane Systematic Review and Meta-Analysis
  133. Insight into erythrocyte phospholipid molecular flux in healthy humans and in patients with acute respiratory distress syndrome
  134. Immunonutrition for acute respiratory distress syndrome (ARDS) in adults
  135. P200 A review of domiciliary non-invasive ventilation for patients with motor neurone disease (MND) in a regional centre
  136. P204 A retrospective study of home non-invasive ventilation for patients with severe COPD in a regional centre
  137. P208 The use of non-invasive ventilation in patients with community acquired pneumonia admitted to the intensive care unit
  138. Perioperative administration of buffered versus non-buffered crystalloid intravenous fluid to improve outcomes following adult surgical procedures: a Cochrane systematic review
  139. Abnormal liver phosphatidylcholine synthesis revealed in patients with acute respiratory distress syndrome
  140. Perioperative administration of buffered versus non-buffered crystalloid intravenous fluid to improve outcomes following adult surgical procedures
  141. Keratinocyte growth factor for the treatment of the acute respiratory distress syndrome (KARE): a randomised, double-blind, placebo-controlled phase 2 trial
  142. Abstracts
  143. Immunonutrition for acute respiratory distress syndrome (ARDS) in adults
  144. Altered molecular specificity of surfactant phosphatidycholine synthesis in patients with acute respiratory distress syndrome
  145. Perceptions of diagnosis and management of patients with acute respiratory distress syndrome: a survey of United Kingdom intensive care physicians
  146. Phospholipid composition and kinetics in different endobronchial fractions from healthy volunteers
  147. Perioperative increase in global blood flow to explicit defined goals and outcomes after surgery: a Cochrane Systematic Review † †This review is an abridged version of a Cochrane Review previously published in the Cochrane Database of Systematic Review...
  148. Proceedings of the Anaesthetic Research Society Meeting
  149. Perioperative buffered versus non-buffered fluid administration for surgery in adults
  150. S18 Bronchoalveolar Lavage, Tracheal Wash and Induced Sputum Surfactant Phospholipid Kinetics from Healthy Volunteers
  151. S58 Surfactant Phospholipid Kinetics in Patients with Acute Respiratory Distress Syndrome (ARDS)
  152. S65 Raised CK Levels in Severe Asthmatics Admitted to the Critical Care Unit- A Retrospective Cohort Analysis
  153. Perioperative increase in global blood flow to explicit defined goals and outcomes following surgery
  154. ESICM 2012 MONDAY SESSIONS 15 October, 2012
  155. Exogenous Surfactant Therapy in Acute Lung Injury/Acute Respiratory Distress Syndrome: The Need for a Revised Paradigm Approach
  156. Clinical review: Exogenous surfactant therapy for acute lung injury/acute respiratory distress syndrome - where do we go from here?
  157. Acute respiratory distress syndrome and acute lung injury
  158. Unusual case of unilateral whiteout on chest radiograph with evidence of previous pulmonary tuberculosis exposure
  159. Nocturia, enuresis and snoring: an unusual combination in an adult?
  160. Multiple pulmonary micronodules in a patient with Crohn's disease
  161. Outcome Of A Cohort Of Older Population With COPD, Admitted With Hypercapnaeic Respiratory Failure And Acidosis
  162. Observed Other Primary Malignancies In Patients With Lung Cancer
  163. Summer-type relapsing fever (hypersensitivity pneumonitis) secondary to Cladosporium herbarum in the domestic environment
  164. Developmental Regulation of p66ShcIs Altered by Bronchopulmonary Dysplasia in Baboons and Humans
  165. Are ColonialHaemophilus influenzaeResponsible for Exacerbations of Chronic Obstructive Pulmonary Disease After All?